• English
  • العربية
  • 中文
  • Français
  • Русский
  • Español

You are here

IAEA Director General Visits Bosnia and Herzegovina and Former Yugoslav Republic of Macedonia


IAEA Director General Yukiya Amano visits the Sarajevo University Clinical Center in Bosnia and Herzegovina. (Photo: State Regulatory Agency for Radiation and Nuclear Safety)

IAEA Director General Yukiya Amano visited Bosnia and Herzegovina and the Former Yugoslav Republic of Macedonia to discuss ways in which the IAEA can support the Balkan nations in the peaceful use of nuclear technology.

Priority areas for Bosnia and Herzegovina include nuclear medicine, radiation protection and animal health, Mr Amano was informed by his hosts.

Mr Amano met Chairman of the Presidency of Bosnia and Herzegovina Mladen Ivanić and Minister of Civil Affairs Adil Osmanović, and visited the State Regulatory Agency for Radiation Safety and Nuclear Safety and the Sarajevo University Clinical Center.

The country is currently benefiting from four IAEA technical cooperation projects. These aim to strengthen the national regulatory infrastructure, improve emergency preparedness and response, enhance nuclear medicine capabilities in positron emission tomography/computed tomography (PET/CT) imaging, and establish national diagnostic reference levels in diagnostic radiology.

New PET Centre in Skopje

In the Former Yugoslav Republic of Macedonia Mr Amano participated in the opening of the University Institute for Positron Emission Tomography in Skopje. The IAEA has supported the establishment of the Institute through technical advice, training of professional staff and the donation of equipment.

“This impressive facility will greatly benefit patients in the country and the wider region suffering from cancer and other conditions,” he said. “It will also provide an important basis for ongoing work to strengthen public cancer care in the Former Yugoslav Republic of Macedonia.”

The new equipment will allow Institute staff to perform diagnosis of cancer and other conditions. It will also serve as a production facility for radiopharmaceuticals, including for export throughout the Balkans.

A nuclear medicine quality management audit by the IAEA at the Institute is planned for November. The Institute has already supported the work of the IAEA by hosting a training course for African radiopharmacists.

Stay in touch